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An antigen-specific suppression of antibody response has been known to be medi- 
ated by the factor (TsF) derived from suppressor T  cells in a  variety of experimental 
systems. An antigen-specific TsF has also been found to bear the products of genes in 
the  I-J subregion  of the  H-2  complex  and  the  antigen-binding  moiety having  no 
known  constant-region  determinants  of the  immunoglobulins  (1-7).  Although  the 
nature of the antigen-binding structure of TsF is still largely unknown, recent reports 
from  various  laboratories  (8-11)  have indicated  that  TsF carries  the  determinants 
analogous to the variable region of the immunoglobulin heavy chain. It is,'therefore, 
conceivable that at least two gene products are involved in the structural entity of an 
antigen-specific TsF: each product coded for by genes in one locus or the other. 
Despite the information mentioned above, the structure of an antigen-specific TsF 
is still controversial. Our recent studies using the extracted TsF from a T  cell hybrid 
specific for keyhole limpet hemocyanin (KLH) have strongly suggested that the TsF 
is composed of the two distinct  polypeptide chains, i.e., the antigen-binding and the 
I-J-encoded chains in noncovalent association (7).  On the other hand, Kontiainen et 
al.  (5)  have indicated  that  these  two  determinants  on  the secreted  TsF specific for 
KLH are present on the same molecule. It is therefore of importance to determine the 
structural entity of an antigen-specific TsF. 
In  this  communication,  we have further examined  the structural  and  functional 
organization of the secreted form of the KLH-specific TsF from the hybridoma 34S- 
704.  We  hereby  demonstrate  that  the  secreted  TsF  is  composed  of  two  distinct 
polypeptide  chains,  i.e.,  the  one  having the  antigen-binding  moiety and  the  other 
having the I-J subregion gene product, in association with disulfide bonds.  Further- 
more,  we  show  that  the  two  dissociated  polypeptide  chains  obtained  after  the 
reduction  of  the  TsF  with  dithiothreitol  (DTT)  can  successfully  reassociate  and 
reconstitute  the  TsF  activity  if  the  reduced  TsF  is  not  alkylated,  and  that  the 
association of these two chains is essential for the expression of the TsF activity. 
Materials and Methods 
Animals.  C57BL/6 mice were purchased from the Shizuoka Experimental Animal Labora- 
tory Co., Ltd., Hamamatsu, Japan. 
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Antigens.  KLH was purchased from Calbiochem-Behring Corp., American Hoechst Corp., 
San Diego, Calif. Dinitrophenylated KLH  (DNP-KLH)  was prepared by coupling with 2,4- 
dinitrobenzensulfonic acid under  an  alkaline condition by the method  of Eisen et  al.  (12). 
Bordetella pertussis vaccine  (BPV)  was  purchased  from  the Chiba Serum  Institute, Chiba, 
Japan. 
Immunoadsorbent Columns.  10 mg of KLH or 1 ml of gammaglobulin fraction of B10.A(5R) 
anti-B10.A(3R) antiserum (anti-I-J  b) was coupled with 1 ml of Sepharose 4B (Pharmacia Fine 
Chemicals, Uppsala, Sweden) by the method of Axen et al. (13). 
Preparation ofKLH-specific  TsF (KLH-TsF).  The KLH-TsF obtained from the aseitic fluid 
of the hybridoma-bearing mice was used. The T  cell hybridoma 34S-704 was made by fusion 
of the AKR thymoma BW5147 and KLH-specific suppressor T cells from KLH-primed spleen 
cells of C57BL/6  mice enriched with KLH-coated Petri dishes as described previously (14). 
The properties of the TsF derived from hybridoma 34S-704 have been described elsewhere (6). 
1 ×  108 hybrid cells (34S-704)  were intraperitoneally inoculated into  (C57BL/6  ×  AKR)F1 
mice.  10 d later, ascitic fluid was collected and 0.5 mM phenylmethylsulfonylfluoride (Sigma 
Chemical Co., St. Louis, Mo.) was added. They were stored in liquid nitrogen (-160°C). 
Purification of the KLH-TsF.  The ascitic fluid from the hybridoma 34S-704-bearing mice was 
applied to an immunoadsorbent column composed of KLH. It was incubated for  1 h at 4°C, 
and the column was extensively washed with 0.01  M  sodium phosphate-buffered saline (PBS), 
pH  7.2.  The active materials were then  eluted from  the column with 0.175  M  glycine-HC1 
buffer,  pH  3.2.  The  eluted  materials were  dialysed with  0.01  M  PBS,  pH  7.2,  and  were 
concentrated by vacuum pressure. 
Reduction and Alkylation of the KLH-TsF.  The purified KLH-TsF was reduced with 5 mM 
DTT at room temperature for 45 min. The reduced materials were subsequently alkylated with 
10 mM iodoacetamide at room temperature for 20 min. The reaction was carried out in 0.15 
M  Tris-HC1 buffer, pH 8.0, containing 2 mM EDTA under the condition of saturated N2. The 
materials were extensively dialysed overnight against 0.01 M PBS, pH 7.2 and concentrated by 
vacuum pressure. In some experiments, the purified TsF was treated with only 5 mM DTT or 
10 mM iodoacetamide under the above conditions. 
Assay for the TsF Activity.  The TsF activity was assayed in the in vitro secondary antibody 
response against DNP-KLH as described in the previous paper (6). Briefly, 4 ×  l0  s spleen cells 
from C57BL/6 mice primed with  100/~g  DNP-KLH plus BPV 4 wk earlier were cultured by 
the Mishell-Dutton system in the presence of 0.1 p,g/ml of DNP-KLH at 37°C in 5% CO2. The 
TsF was added to the culture on day 0. 5 d later, the numbers of anti-DNP IgG plaque-forming 
cells (PFC) were assayed by using DNP-coupled sheep erythrocytes. 
statistics.  For in vitro assays, results were analyzed with a two-tailed Student's t test. 
Results and  Discussion 
Our  previous  studies  (6)  have  shown  that  the  KLH-TsF  in  the  extracted or  the 
secreted materials derived  from  the T  cell hybridoma  34S-704  carries the  antigen- 
binding  moiety  and  the  I-J-encoded  determinants.  Furthermore,  by  using  the  ex- 
tracted TsF, these two distinct determinants have been  found to be on the different 
polypeptide chains in noncovalent  association. On the other hand,  the secreted TsF 
has  different  features  from  the  extracted  TsF,  possessing  the  two  characteristic 
determinants on the same molecule (7). These data have therefore indicated that the 
antigen-binding and the I-J-encoded polypeptide chains are noncovalently linked in 
cytoplasm  or  on  the  cell  surface,  and  that  they  are  secreted  after  their  covalent 
association. 
To test this possibility, the secreted TsF was examined to determine the presence of 
the interchain disulfide bonds and to cleave into the two polypeptide chains. 800/~1 
of the  ascites  from  the  hybridoma  34S-704-bearing  mice  was  applied  to  a  KLH 
column. The active KLH-TsF was then eluted with 0.175  M  glycine-HCl buffer, pH 
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TABLE  I 
Reduction and A lkylation of the Secreted KLH-TsF Derioed  from a T Cell 
Hybridoma 
Anti-DNP lgG PFC/  Significance of 
KLH-TsF treated with 
culture*  difference:~ 
--  2,394 +  301 
Untreated  798:1:120  P <  0.01 
5 mM DTT and 10 mM  2,100 +  180  P> 0.3 
iodoacetamide 
5 mM DTT  725 +-  139  P<  0.01 
10 mM iodoacetamide  651 --. 138  P<  0~01 
The secreted KLH-TsF purified with the KLH column was reduced and/or alkylated as 
indicated in Materials and Methods. The materials were then tested for their activity in 
the in vitro secondary antibody response. 
* Arithmetic mean numbers of anti-DNP lgO PFC of four cultures ±  SD. 
:~ Student's t tests, when compared with the control group. 
mM iodoacetamide.  In other experiments, the purified TsF was treated only with 5 
mM DTT or with  10 mM iodoacetamide under the same conditions  as above. The 
materials thus obtained were extensively dialysed and tested for their activity in the 
culture of spleen cells primed with DNP-KLH plus BPV. As shown in Table I, the 
suppressor  activity of the  purified TsF was completely abrogated by the  reduction 
and alkylation.  In contrast,  the activity was still  preserved by the  treatment  of the 
TsF with only one of DTT or iodoacetamide.  Although  there is no direct evidence 
that the treatment of the TsF with 5 mM DTT does not cleave the intrachain disulfide 
bonds, the same treatment has been demonstrated not to affect the intrachain disulfide 
bonds of immunoglobulins  (15).  Therefore, these results strongly suggest that  there 
are interchain disulfide bonds between the antigen-binding and I-J-encoded polypep- 
tide chains  of the secreted TsF, and that  the cleaved chains successfully reassociate 
and reconstitute the active form of the TsF. 
Because our previous studies (7) using the extracted TsF have clearly indicated that 
the association of the antigen-binding and the I-J chains is necessary for the expression 
of the TsF activity, we therefore tried to test whether the suppressor activity obtained 
by the reduced TsF is due to the reassociation of the cleaved two chains of the secreted 
TsF. 
The secreted KLH-TsF reduced with 5 mM DTT was applied to the KLH column 
equilibrated  with  Tris-HC1  buffer,  pH  8.0,  containing  0.5  mM  DTT,  in  order  to 
separate the antigen-binding polypeptide chains from the I-J products. The materials 
bound  to the  KLH column  were eluted  with 0.175  M  glycine-HC1 buffer, pH  3.2. 
The effluent, the eluate, and the mixture of the half volume of these two were tested 
for their activity. As shown in Fig.  1, the suppressor activity was still preserved in the 
reduced  materials of the TsF.  However, when  they were fractionated by the  KLH 
column,  no  significant  activity was  observed  in  the  effluent  or  the  eluate.  On  the 
other hand, the mixture of the half volume of the effluent and the eluate reconstituted 
strong suppressor activity. This indicates that the combination of the materials in the 
effluent and those in the eluate composes the active TsF. 
Further,  to investigate whether the two distinct  materials in the effluent and the 
eluate  of the  reduced  TsF  from  the  KLH  column  (lst  column;  designated  as  the 
effluent KLH and the eluate KLH) are in fact the antigen-binding and I-J-encoded 
polypeptide chains, the half volume of the dialysed effluent or eluate from the KLH TANIGUCHI ET  AL.  BRIEF  DEFINITIVE REPORT  1675 
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F[o.  1.  Successful  reconstitution of the TsF activity in the mixture of the effluent and the acid 
eluate from the KLH column having absorbed the reduced TsF. The secreted  TsF reduced with 5 
mM DTT was fractionated by the KLH column in the presence of 0.5 mM DTT. The effluent, the 
eluate, and the mixture of the half volume of the two were tested for their activity. The bars indicate 
the mean PFC numbers ±  SD of four cultures.  Student's t tests, unabsorbed TsF, P <  0.01 ; reduced 
TsF, P <  0.01; eluate, P >  0.5; effluent, P >  0.2; eluate +  effluent, P <  0.001. 
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Fro.  2.  Reconstitution of the TsF activity with the combination of the antigen-binding and I-J- 
encoded chains.  The half volume of the effluent or the eluate of the reduced TsF from the KLH 
column was successively absorbed with the KLH and anti-I-J  b columns.  The acid eluate from the 
column were mixed and made two groups,  A and B, as indicated in panel a. The activity of group 
A or B was tested and demonstrated in panel b. The bars indicate the mean PFC numbers :t: SD of 
four cultures.  Student's t tests. Reduced TsF, P <  0.01; group A, P >  0.3; group B, P <  0.05. 
column, each of which had no activity, was successively absorbed  with the KLH  and 
anti-IoJ  b columns.  The  acid eluates  from the second columns  were mixed and  made 
into  two different  groups  (A and  B)  as  indicated  in  Fig.  2a.  Group  A  consists of the 
mixture  of the  eluate  from  the  second  KLH  column,  having  absorbed  the  effluent 
KLH,  and that from the anti-I-J column having absorbed  the eluate KLH.  Similarly, 
group  B  is composed  of the  mixture  of the eluate  from  the anti-I-J  column,  having 
absorbed  the effluent KLH,  and that  from the second KLH  column having absorbed 
the  eluate  KLH.  As  shown  in  Fig.  2b,  group  B  gave  a  strong  suppressor  activity, 
whereas  no  detectable  effect was  observed  by  group  A.  From  the  results,  it  is  clear 
that  the antigen-binding  and  I-J-encoded polypeptide chains of the secreted TsF are 
cleaved by the DTT  treatment,  and  it is most likely that  they are easy to reassociate 
to compose  the  active TsF,  although  the experiments  do  not  exclude  the  possibility 
that  the two distinct chains without  direct linkage would be active on the target cells. 
The polypeptide chain with antigen-binding  capacity per se could directly bind to 
the  antigen  but  not  exert  the  TsF  activity,  so  that  it  acts  as  the  element  for  the 
antigen-specificity of the TsF. Concerning the role of the I-J product on TsF, it should 1676  TANIGUCHI ET AL.  BRIEF  DEFINITIVE REPORT 
act  as  a  functional  molecule  to convey suppressor  activity.  However, this  does not 
imply that the I-J products themselves could exert their suppressor function, because 
the  effluent  of the  reduced  TsF  from the  KLH  column,  which  should  contain  I-J 
products,  did  not  show  any  suppressor  activity  (see  Fig.  1).  Therefore,  it  can  be 
concluded  that  the KLH-TsF is composed of the two distinct  gene products of the 
KLH-binding and I-J-encoded polypeptide chains, and that the association of these 
two chains is essential for the expression of the KLH-TsF function. In this sense, the 
covalent association of these two chains with disulfide bonds may keep the TsF more 
stable even after they were secreted. 
In any event, the KLH-TsF reported in this paper resembles other antigen-specific 
T  cell factors with suppressor function reported by Theze et al.  (2), and Kontiainen 
et al. (5), and with helper function as described by Taussig et al. (16), Isac et al. (17), 
and Tokuhisa et al. (18). In particular, the antigen-specific helper T  cell factors have 
also demonstrated  that  they have the antigen-binding  moiety and  the  I-A-encoded 
determinants.  Therefore, it appears that  the  I-region gene products  (i.e.,  I-A or I-J 
products) detected on the antigen-specific helper and suppressor factors in association 
with the antigen-binding moiety directly reflect the function of the T  cell factors. 
Summary 
The  secreted  form  of  the  suppressor  T  cell  factor  specific  for  keyhole  limpet 
hemocyanin derived  from the  hybridoma  34S-704  was  found  to consist  of the  two 
distinct polypeptide chains, i.e., the antigen-binding and the I-J-encoded chains. They 
were linked in covalent association with disulfide bonds. The two chains were cleaved 
by the reduction with dithiothreitol  and were easy to reconstitute the active form of 
TsF. The association of the two distinct  chains was suggested to he essential for the 
expression of the TsF activity. 
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